444 related articles for article (PubMed ID: 28803385)
41. Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method.
Miyake M; Nishimura N; Nakai Y; Fujii T; Owari T; Hori S; Morizawa Y; Gotoh D; Anai S; Torimoto K; Tanaka N; Hirao Y; Fujimoto K
Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33525423
[TBL] [Abstract][Full Text] [Related]
42. Time to Turn on the Blue Lights: A Systematic Review and Meta-analysis of Photodynamic Diagnosis for Bladder Cancer.
Veeratterapillay R; Gravestock P; Nambiar A; Gupta A; Aboumarzouk O; Rai B; Vale L; Heer R
Eur Urol Open Sci; 2021 Sep; 31():17-27. PubMed ID: 34467237
[TBL] [Abstract][Full Text] [Related]
43. Feasibility of photodynamic diagnosis for challenging TUR- Bt cases including muscle invasive bladder cancer, BCG failure or 2nd-TUR.
Takai T; Inamoto T; Komura K; Yoshikawa Y; Uchimoto T; Saito K; Tanda N; Kouno J; Minami K; Uehara H; Takahara K; Hirano H; Nomi H; Kiyama S; Azuma H
Asian Pac J Cancer Prev; 2015; 16(6):2297-301. PubMed ID: 25824753
[TBL] [Abstract][Full Text] [Related]
44. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
[TBL] [Abstract][Full Text] [Related]
45. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis.
Burger M; Zaak D; Stief CG; Filbeck T; Wieland WF; Roessler W; Denzinger S
Eur Urol; 2007 Jul; 52(1):142-7. PubMed ID: 17267099
[TBL] [Abstract][Full Text] [Related]
46. [Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis].
Kausch I; Sommerauer M; Montorsi F; Stenzl A; Jacqmin D; Jichlinski P; Jocham D; Ziegler A; Vonthein R
Aktuelle Urol; 2010 May; 41(3):171-7. PubMed ID: 20486035
[TBL] [Abstract][Full Text] [Related]
47. Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?
Alsyouf M; Ladi-Seyedian SS; Konety B; Pohar K; Holzbeierlein JM; Kates M; Willard B; Taylor JM; Liao JC; Kaimakliotis HZ; Porten SP; Steinberg GD; Tyson MD; Lotan Y; Daneshmand S;
Urol Oncol; 2023 Feb; 41(2):109.e9-109.e14. PubMed ID: 36435710
[TBL] [Abstract][Full Text] [Related]
48. DaBlaCa-11: Photodynamic Diagnosis in Flexible Cystoscopy-A Randomized Study With Focus on Recurrence.
Drejer D; Moltke AL; Nielsen AM; Lam GW; Jensen JB
Urology; 2020 Mar; 137():91-96. PubMed ID: 31843623
[TBL] [Abstract][Full Text] [Related]
49. Variations in photodynamic diagnosis for bladder cancer due to the quality of endoscopic equipment.
Nohara T; Kamijima T; Fukuda R; Kano H; Shimada T; Nakano T; Kato Y; Kadomoto S; Iwamoto H; Yaegashi H; Iijima M; Kawaguchi S; Shigehara K; Izumi K; Kadono Y; Mizokami A
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102628. PubMed ID: 34808397
[TBL] [Abstract][Full Text] [Related]
50. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.
Burger M; Grossman HB; Droller M; Schmidbauer J; Hermann G; Drăgoescu O; Ray E; Fradet Y; Karl A; Burgués JP; Witjes JA; Stenzl A; Jichlinski P; Jocham D
Eur Urol; 2013 Nov; 64(5):846-54. PubMed ID: 23602406
[TBL] [Abstract][Full Text] [Related]
51. Continuous saline bladder irrigation after blue light transurethral resection of bladder tumor increases recurrence-free survival in low- to intermediate-risk non-muscle invasive bladder cancer.
Gondran-Tellier B; Abdallah R; Sichez PC; Akiki A; Toledano H; Gaillet S; Delaporte V; Karsenty G; Bastide C; Daniel L; Garcia S; Rossi D; Lechevallier E; Boissier R; Baboudjian M
Prog Urol; 2021 May; 31(6):316-323. PubMed ID: 33663939
[TBL] [Abstract][Full Text] [Related]
52. The HELENA study: Hexvix
Gierth M; Breyer J; Zeman F; Fritsche HM; Cordes J; Karl A; Zaak D; Stenzl A; von Schmeling IK; Sommerhuber A; Zierer T; Burger M; Mayr R
World J Urol; 2021 Oct; 39(10):3799-3805. PubMed ID: 34002265
[TBL] [Abstract][Full Text] [Related]
53. Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
May M; Fritsche HM; Vetterlein MW; Bastian PJ; Gierth M; Nuhn P; Aziz A; Fisch M; Stief CG; Hohenfellner M; Wirth MP; Novotny V; Hakenberg OW; Noldus J; Gilfrich C; Bolenz C; Burger M; Brookman-May SD;
World J Urol; 2017 Feb; 35(2):245-250. PubMed ID: 27300339
[TBL] [Abstract][Full Text] [Related]
54. [A systematic review and meta-analysis to assess the recurrence-free survival in non-muscle invasive bladder cancer after transurethral resection guided by 5-aminolevulinic acid-induced photodynamic diagnosis compared with white-light transurethral resect].
Rolevich AI; Evmenenko AA
Urologiia; 2016 Aug; (4):137-146. PubMed ID: 28247741
[TBL] [Abstract][Full Text] [Related]
55. Observational Studies Requested by European Health Authorities: Governmental Interference or an Enhancement of Everyday Urological Practice? The Hexvix® Observational Patients Evaluation Study as an Example of What to Expect.
Jacqmin D; Jichlinski P; Molinier L; de la Taille A; Irani J; Malavaud B
Urol Int; 2017; 99(3):358-366. PubMed ID: 28787725
[TBL] [Abstract][Full Text] [Related]
56. Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer.
Rolevich AI; Zhegalik AG; Mokhort AA; Minich AA; Vasilevich VY; Polyakov SL; Krasny SA; Sukonko OG
World J Urol; 2017 May; 35(5):745-752. PubMed ID: 27604374
[TBL] [Abstract][Full Text] [Related]
57. Innovations in the endoscopic management of bladder cancer: is the era of white light cystoscopy over.
Soria F; Gurioli A; Peraldo F; Oderda M; Giona S; Ambrosini E; Frea B; Gontero P
Urologia; 2013 Jun; 80 Spec No 1():1-8. PubMed ID: 23813287
[TBL] [Abstract][Full Text] [Related]
58. [Is a routine second transurethral resection of the bladder still necessary after hexaminolévulinate photodynamic diagnosis-assisted TURBT?].
Doisy L; Walz J; Fakhfakh S; Rybikowski S; Koskas Y; Gravis G; Pignot G
Prog Urol; 2019; 29(6):332-339. PubMed ID: 31104952
[TBL] [Abstract][Full Text] [Related]
59. Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study.
Inoue K; Anai S; Fujimoto K; Hirao Y; Furuse H; Kai F; Ozono S; Hara T; Matsuyama H; Oyama M; Ueno M; Fukuhara H; Narukawa M; Shuin T
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):193-200. PubMed ID: 25843912
[TBL] [Abstract][Full Text] [Related]
60. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
Geavlete B; Multescu R; Georgescu D; Jecu M; Stanescu F; Geavlete P
BJU Int; 2012 Feb; 109(4):549-56. PubMed ID: 21711438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]